|
| Exchange Disseminated Time | Jubilant Life Sciences Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 24, 2016, inter alia, to consider:
1. Audited Financial Results of the Company for the year ended March 31, 2016;
2. Recommendation of Dividend for the year ended March 31, 2016.
Further, as per the Company's Code of Conduct for Prevention of Insider Trading, the Trading Window for dealing in the securities of the Company would remain closed for the Designated Persons of the Company from May 17, 2016 to May 26, 2016 (both days inclusive). |
|
|